Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Gene Ther. 2010 Apr 29;17(11):1325–1332. doi: 10.1038/gt.2010.63

FIGURE 6. Efficacy Studies.

FIGURE 6

Mice were subcutaneously engrafted with LnCaP, one group of mice was used as control (C), a second group received a unique intratumoral dose of Ad5PB_RSV-NIS at 1011 vp (virotherapy V), and the third group received a unique intratumoral dose of Ad5PB_RSV-NIS at 1011 vp and 4 days later a single intraperitoneal dose of 3mCi 131I (radiovirotherapy V+I). For each group n=10. A) Tumor growth kinetics. B) Survival was analyzed according to Kaplan-Meier (t test p=0.001)